Interview with Dr. Peter Neumann on the use of various new value-based frameworks for assessing drugs and drug prices. (08:22)Download In the face of the growing cost of cancer care, the American Society of Clinical Oncology has published a proposed framework for assessing the value of cancer treatments, aiming to help physicians evaluate regimens on the basis of clinical benefit, toxicity, and cost.
No takes yet. Share an insight, caveat, or question.
Robert C. Young (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: